iSpecimen Inc. Other Income and Expense
iSpecimen Inc. (ISPC) reported Other Income and Expense of $175 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-14
- iSpecimen Inc. nonoperating income (expense) for the quarter ending 2026-06-30 was $175.00, a 99.98% decline year-over-year.
- iSpecimen Inc. nonoperating income (expense) for the quarter ending 2026-03-31 was $263.18K.
- iSpecimen Inc. nonoperating income (expense) for the quarter ending 2025-12-31 was -$2.31M.
- iSpecimen Inc. nonoperating income (expense) for the quarter ending 2025-09-30 was $49.57K, a 81.33% decline year-over-year.
- iSpecimen Inc. nonoperating income (expense) for fiscal 2025 was -$1.51M, a 755.67% decline from fiscal 2024.
- iSpecimen Inc. nonoperating income (expense) for fiscal 2024 was $230.24K, a 229.57% increase from fiscal 2023.
- iSpecimen Inc. nonoperating income (expense) for fiscal 2023 was $69.86K.
- iSpecimen Inc. nonoperating income (expense) for fiscal 2022 was -$59.84K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $175.00 10-Q · filed 2026-08-14 | $263.36K 10-Q · filed 2026-08-14 | -$2.05M derived: sum of 3 quarters · filed 2026-08-14 | -$2.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $263.18K 10-Q · filed 2026-05-18 | -$2.05M derived: sum of 2 quarters · filed 2026-05-18 | -$2.00M derived: sum of 3 quarters · filed 2026-05-18 | -$1.23M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$2.26M derived: sum of 2 quarters · filed 2026-04-01 | -$1.49M derived: sum of 3 quarters · filed 2026-08-14 | -$1.51M 10-K · filed 2026-04-01 |
| 2025-09-30 | $49.57K 10-Q · filed 2025-11-17 | $823.76K derived: sum of 2 quarters · filed 2026-08-14 | $803.75K 10-Q · filed 2025-11-17 | $597.39K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $774.18K 10-Q · filed 2026-08-14 | $754.18K 10-Q · filed 2026-08-14 | $547.82K derived: sum of 3 quarters · filed 2026-08-14 | $813.37K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$20.01K 10-Q · filed 2026-05-18 | -$226.36K derived: sum of 2 quarters · filed 2026-05-18 | $39.19K derived: sum of 3 quarters · filed 2026-05-18 | $111.83K derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | -$206.35K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $59.20K derived: sum of 2 quarters · filed 2026-04-01 | $131.84K derived: sum of 3 quarters · filed 2026-04-01 | $230.24K 10-K · filed 2026-04-01 |
| 2024-09-30 | $265.55K 10-Q · filed 2025-11-17 | $338.19K derived: sum of 2 quarters · filed 2025-11-17 | $436.60K 10-Q · filed 2025-11-17 | $234.66K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $72.64K 10-Q · filed 2025-08-14 | $171.04K 10-Q · filed 2025-08-14 | -$30.89K derived: sum of 3 quarters · filed 2025-08-14 | $52.09K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $98.40K 10-Q · filed 2025-05-19 | -$103.53K derived: sum of 2 quarters · filed 2025-05-19 | -$20.55K derived: sum of 3 quarters · filed 2025-05-19 | $57.65K derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | -$201.94K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | -$118.96K derived: sum of 2 quarters · filed 2025-04-14 | -$40.75K derived: sum of 3 quarters · filed 2025-04-14 | $69.86K 10-K · filed 2025-04-14 |
| 2023-09-30 | $82.98K 10-Q · filed 2024-11-07 | $161.19K derived: sum of 2 quarters · filed 2024-11-07 | $271.80K 10-Q · filed 2024-11-07 | $253.75K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $78.21K 10-Q · filed 2024-08-06 | $188.82K 10-Q · filed 2024-08-06 | $170.77K derived: sum of 3 quarters · filed 2024-08-06 | $176.14K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $110.61K 10-Q · filed 2024-05-07 | $92.56K derived: sum of 2 quarters · filed 2024-05-07 | $97.93K derived: sum of 3 quarters · filed 2024-05-07 | $76.13K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$18.05K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$12.68K derived: sum of 2 quarters · filed 2024-03-13 | -$34.49K derived: sum of 3 quarters · filed 2024-03-13 | -$59.84K 10-K · filed 2024-03-13 |
| 2022-09-30 | $5.37K 10-Q · filed 2023-11-02 | -$16.43K derived: sum of 2 quarters · filed 2023-11-02 | -$41.79K 10-Q · filed 2023-11-02 | -$97.18K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$21.80K 10-Q · filed 2023-08-02 | -$47.16K 10-Q · filed 2023-08-02 | -$102.55K derived: sum of 3 quarters · filed 2023-08-02 | -$196.50K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$25.35K 10-Q · filed 2023-05-04 | -$80.74K derived: sum of 2 quarters · filed 2023-05-04 | -$174.69K derived: sum of 3 quarters · filed 2023-05-04 | |
| 2021-12-31 | -$55.39K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | -$149.34K derived: sum of 2 quarters · filed 2023-03-30 | -$3.04M 10-K/A · filed 2023-03-30 | |
| 2021-09-30 | -$93.95K 10-Q · filed 2022-11-08 | -$2.98M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |